Limited coverage drugs – mercaptopurine

Last updated on August 23, 2024

Generic Name / Strength / Form

mercaptopurine

Criteria

Approval period

1. Diagnosis of ulcerative colitis.

OR

2. Diagnosis of autoimmune hepatitis.

OR

3. Diagnosis of inflammatory bowel disease.

OR

4. Diagnosis of Crohn's disease.

Indefinite

Practitioner exemptions

  • No practitioner exemptions

Special notes

  • For any cancer related condition, please contact the British Columbia Cancer Agency at (604) 877-6098 ext. 4610.

Special Authority request form(s)